

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.23546961 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.23546961 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.91579594 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.91579594 |
| 5 | thymic T cell selection (GO:0045061) | 4.44858139 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.40641299 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.39494490 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.20761139 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.20761139 |
| 10 | viral transcription (GO:0019083) | 4.14579995 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.10606654 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 4.02554135 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.02554135 |
| 14 | negative T cell selection (GO:0043383) | 3.98146643 |
| 15 | detection of bacterium (GO:0016045) | 3.92691862 |
| 16 | translational termination (GO:0006415) | 3.88410652 |
| 17 | T cell selection (GO:0045058) | 3.85180403 |
| 18 | mannose metabolic process (GO:0006013) | 3.83241092 |
| 19 | * positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.81106326 |
| 20 | leukocyte aggregation (GO:0070486) | 3.69334723 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.66197355 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.66197355 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.66197355 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.66197355 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.66197355 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.66197355 |
| 27 | detection of other organism (GO:0098543) | 3.65886732 |
| 28 | aromatic amino acid family catabolic process (GO:0009074) | 3.64143274 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.61308831 |
| 30 | NIK/NF-kappaB signaling (GO:0038061) | 3.61185187 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.58831780 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.55180301 |
| 33 | positive T cell selection (GO:0043368) | 3.54291144 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 3.53120016 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48759869 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 3.48499555 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.42043393 |
| 38 | translational elongation (GO:0006414) | 3.42010736 |
| 39 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.40639490 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 3.39330731 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 3.39330731 |
| 42 | tryptophan catabolic process (GO:0006569) | 3.39330731 |
| 43 | valine metabolic process (GO:0006573) | 3.37221144 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.36841533 |
| 45 | cysteine metabolic process (GO:0006534) | 3.33647803 |
| 46 | protein targeting to ER (GO:0045047) | 3.30316454 |
| 47 | cotranslational protein targeting to membrane (GO:0006613) | 3.28136195 |
| 48 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.27812054 |
| 49 | tolerance induction (GO:0002507) | 3.26160084 |
| 50 | kynurenine metabolic process (GO:0070189) | 3.25681924 |
| 51 | response to interleukin-15 (GO:0070672) | 3.23403489 |
| 52 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.22937850 |
| 53 | regulation of B cell differentiation (GO:0045577) | 3.22239840 |
| 54 | glyoxylate metabolic process (GO:0046487) | 3.22148354 |
| 55 | * response to type I interferon (GO:0034340) | 3.21844682 |
| 56 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.21256575 |
| 57 | tryptophan metabolic process (GO:0006568) | 3.20090843 |
| 58 | negative regulation of innate immune response (GO:0045824) | 3.19535709 |
| 59 | ribosomal small subunit biogenesis (GO:0042274) | 3.15666555 |
| 60 | alpha-linolenic acid metabolic process (GO:0036109) | 3.15040061 |
| 61 | * cellular response to type I interferon (GO:0071357) | 3.14967352 |
| 62 | * type I interferon signaling pathway (GO:0060337) | 3.14967352 |
| 63 | urea metabolic process (GO:0019627) | 3.14719820 |
| 64 | urea cycle (GO:0000050) | 3.14719820 |
| 65 | glycine metabolic process (GO:0006544) | 3.14685802 |
| 66 | bile acid biosynthetic process (GO:0006699) | 3.14424066 |
| 67 | protein localization to endoplasmic reticulum (GO:0070972) | 3.11029684 |
| 68 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.10737863 |
| 69 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.09534114 |
| 70 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.08857727 |
| 71 | T cell migration (GO:0072678) | 3.08817406 |
| 72 | ethanol oxidation (GO:0006069) | 3.08017347 |
| 73 | negative regulation of phagocytosis (GO:0050765) | 3.06905019 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.06576563 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06180632 |
| 76 | negative regulation of fibrinolysis (GO:0051918) | 3.05747518 |
| 77 | regulation of gamma-delta T cell activation (GO:0046643) | 3.05435161 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.03827076 |
| 79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.03528978 |
| 80 | neutrophil activation involved in immune response (GO:0002283) | 3.02578496 |
| 81 | response to peptidoglycan (GO:0032494) | 3.02455317 |
| 82 | phospholipid efflux (GO:0033700) | 2.99033456 |
| 83 | complement activation, alternative pathway (GO:0006957) | 2.98585461 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.95496707 |
| 85 | germinal center formation (GO:0002467) | 2.93359918 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 2.92628159 |
| 87 | lysine metabolic process (GO:0006553) | 2.92163938 |
| 88 | lysine catabolic process (GO:0006554) | 2.92163938 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 2.91979620 |
| 90 | nitrogen cycle metabolic process (GO:0071941) | 2.88276320 |
| 91 | viral life cycle (GO:0019058) | 2.88260339 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87938968 |
| 93 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.87834873 |
| 94 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87483387 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 2.87214807 |
| 96 | cellular response to interleukin-15 (GO:0071350) | 2.87187719 |
| 97 | regulation of protein activation cascade (GO:2000257) | 2.86187219 |
| 98 | regulation of triglyceride catabolic process (GO:0010896) | 2.86136272 |
| 99 | high-density lipoprotein particle remodeling (GO:0034375) | 2.85587698 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 2.84091888 |
| 101 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83529588 |
| 102 | GDP-mannose metabolic process (GO:0019673) | 2.83348060 |
| 103 | serine family amino acid catabolic process (GO:0009071) | 2.82694443 |
| 104 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.82105299 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 2.81954973 |
| 106 | modulation by virus of host process (GO:0019054) | 2.81189792 |
| 107 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81091208 |
| 108 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.80709685 |
| 109 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.80709685 |
| 110 | cellular protein complex disassembly (GO:0043624) | 2.80632961 |
| 111 | regulation of fibrinolysis (GO:0051917) | 2.80273076 |
| 112 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.79816241 |
| 113 | urate metabolic process (GO:0046415) | 2.79237631 |
| 114 | regulation of cholesterol metabolic process (GO:0090181) | 2.79079635 |
| 115 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.76189604 |
| 116 | DNA deamination (GO:0045006) | 2.76087832 |
| 117 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.75657534 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 2.75168605 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 2.74558797 |
| 120 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.74492598 |
| 121 | maturation of SSU-rRNA (GO:0030490) | 2.74327479 |
| 122 | detection of external biotic stimulus (GO:0098581) | 2.73774004 |
| 123 | serine family amino acid metabolic process (GO:0009069) | 2.72558616 |
| 124 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.72364438 |
| 125 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72069064 |
| 126 | positive regulation of histone deacetylation (GO:0031065) | 2.71907394 |
| 127 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71865788 |
| 128 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.71795562 |
| 129 | regulation of complement activation (GO:0030449) | 2.71446380 |
| 130 | respiratory burst (GO:0045730) | 2.70669136 |
| 131 | regulation of tolerance induction (GO:0002643) | 2.70641865 |
| 132 | protein carboxylation (GO:0018214) | 2.69100828 |
| 133 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.69100828 |
| 134 | defense response to protozoan (GO:0042832) | 2.68636567 |
| 135 | negative regulation of cholesterol transport (GO:0032375) | 2.67782143 |
| 136 | negative regulation of sterol transport (GO:0032372) | 2.67782143 |
| 137 | ethanol metabolic process (GO:0006067) | 2.66672960 |
| 138 | flavonoid metabolic process (GO:0009812) | 2.66615560 |
| 139 | bile acid and bile salt transport (GO:0015721) | 2.66459987 |
| 140 | aromatic amino acid family metabolic process (GO:0009072) | 2.66318933 |
| 141 | B cell mediated immunity (GO:0019724) | 2.66286976 |
| 142 | B cell homeostasis (GO:0001782) | 2.65457226 |
| 143 | amino-acid betaine metabolic process (GO:0006577) | 2.64863091 |
| 144 | translational initiation (GO:0006413) | 2.64121385 |
| 145 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.64106008 |
| 146 | interferon-gamma secretion (GO:0072643) | 2.63852377 |
| 147 | homocysteine metabolic process (GO:0050667) | 2.62025897 |
| 148 | primary alcohol catabolic process (GO:0034310) | 2.61448322 |
| 149 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.61273396 |
| 150 | regulation of leukocyte degranulation (GO:0043300) | 2.58608710 |
| 151 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.58576487 |
| 152 | bile acid metabolic process (GO:0008206) | 2.58285255 |
| 153 | fatty acid beta-oxidation (GO:0006635) | 2.56730318 |
| 154 | positive thymic T cell selection (GO:0045059) | 2.56313379 |
| 155 | response to protozoan (GO:0001562) | 2.55235849 |
| 156 | Peyers patch development (GO:0048541) | 2.54749131 |
| 157 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.54749131 |
| 158 | lymphocyte homeostasis (GO:0002260) | 2.54669983 |
| 159 | T cell receptor signaling pathway (GO:0050852) | 2.52817222 |
| 160 | drug transmembrane transport (GO:0006855) | 2.52715077 |
| 161 | cellular response to interleukin-4 (GO:0071353) | 2.52211778 |
| 162 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 2.50954952 |
| 163 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.50794755 |
| 164 | reverse cholesterol transport (GO:0043691) | 2.50119559 |
| 165 | modulation by symbiont of host cellular process (GO:0044068) | 2.49918049 |
| 166 | L-serine metabolic process (GO:0006563) | 2.49371748 |
| 167 | positive regulation of granulocyte differentiation (GO:0030854) | 2.49234807 |
| 168 | negative regulation of interleukin-12 production (GO:0032695) | 2.49197497 |
| 169 | T cell costimulation (GO:0031295) | 2.48757407 |
| 170 | lymphocyte migration (GO:0072676) | 2.47954870 |
| 171 | nucleoside salvage (GO:0043174) | 2.47843426 |
| 172 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.46913068 |
| 173 | alpha-amino acid catabolic process (GO:1901606) | 2.46835300 |
| 174 | lymphocyte costimulation (GO:0031294) | 2.44666430 |
| 175 | drug transport (GO:0015893) | 2.44215248 |
| 176 | regulation of cholesterol esterification (GO:0010872) | 2.43830424 |
| 177 | protein complex disassembly (GO:0043241) | 2.43415546 |
| 178 | phospholipid scrambling (GO:0017121) | 2.43143793 |
| 179 | pentose-phosphate shunt (GO:0006098) | 2.42631150 |
| 180 | imidazole-containing compound metabolic process (GO:0052803) | 2.42600227 |
| 181 | complement activation, classical pathway (GO:0006958) | 2.42397256 |
| 182 | regulation of defense response to virus by virus (GO:0050690) | 2.41915718 |
| 183 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.41859999 |
| 184 | nucleotide salvage (GO:0043173) | 2.39247787 |
| 185 | protein-lipid complex remodeling (GO:0034368) | 2.39060458 |
| 186 | macromolecular complex remodeling (GO:0034367) | 2.39060458 |
| 187 | plasma lipoprotein particle remodeling (GO:0034369) | 2.39060458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.98023321 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.34804695 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.30384245 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.26735385 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.12489823 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.87229390 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.72671833 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.72317149 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.53094452 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32090095 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.28674178 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28618266 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23119781 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.18934271 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11072085 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09427698 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05515113 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.99452602 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.96982751 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.96736408 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94149673 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92081929 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89510744 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88641519 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88626752 |
| 26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.86690055 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.78499637 |
| 28 | P68_20966046_ChIP-Seq_HELA_Human | 1.76671961 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76519004 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76357515 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75093838 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.73783156 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68237337 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67296616 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65149980 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62580801 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.61999565 |
| 38 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.58804689 |
| 39 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.58215109 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55802599 |
| 41 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.54316762 |
| 42 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.52918039 |
| 43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.51277885 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50578076 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47125842 |
| 46 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46365038 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.45190859 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44175540 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42851384 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.41378943 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40884644 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39029127 |
| 53 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.38996433 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37740424 |
| 55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.36465471 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.34955959 |
| 57 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.34683995 |
| 58 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.34645750 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33966956 |
| 60 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33091327 |
| 61 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.33009719 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.32883603 |
| 63 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31794719 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31057991 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30830265 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30755590 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30522615 |
| 68 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29983128 |
| 69 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29870922 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27565746 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27431393 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27376878 |
| 73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26807280 |
| 74 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26316787 |
| 75 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26223199 |
| 76 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25659511 |
| 77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24767612 |
| 78 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24529039 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24084945 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22827612 |
| 81 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22209960 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.21035138 |
| 83 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19738149 |
| 84 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19706729 |
| 85 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.17769129 |
| 86 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16996045 |
| 87 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15797034 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14512765 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.12851395 |
| 90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12618345 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11824138 |
| 92 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11660331 |
| 93 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.10684225 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10548360 |
| 95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10534761 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10505795 |
| 97 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09717936 |
| 98 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09349071 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09161151 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09035341 |
| 101 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08577660 |
| 102 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08574997 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08390929 |
| 104 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07902580 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07866072 |
| 106 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.07145597 |
| 107 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06916228 |
| 108 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06672803 |
| 109 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06316083 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06313440 |
| 111 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.06296612 |
| 112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.06263004 |
| 113 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.05772039 |
| 114 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04935416 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04811676 |
| 116 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.04435533 |
| 117 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04274963 |
| 118 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04238933 |
| 119 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03945103 |
| 120 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03925298 |
| 121 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.03823736 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03410270 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03217373 |
| 124 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.03173730 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02922708 |
| 126 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.02794197 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01531001 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01120056 |
| 129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00980634 |
| 130 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00607345 |
| 131 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.00563421 |
| 132 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99867913 |
| 133 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.99299209 |
| 134 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98150082 |
| 135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96591688 |
| 136 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96393778 |
| 137 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.96035975 |
| 138 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95840409 |
| 139 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95449281 |
| 140 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95013880 |
| 141 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92856300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.07877277 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.04186712 |
| 3 | MP0005365_abnormal_bile_salt | 3.26485018 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.13434403 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 2.81220552 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.68284576 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.56781441 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.38892774 |
| 9 | MP0000685_abnormal_immune_system | 2.37268093 |
| 10 | MP0009840_abnormal_foam_cell | 2.27214206 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.09631001 |
| 12 | MP0003252_abnormal_bile_duct | 2.09042280 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.04974768 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.00572387 |
| 15 | MP0003172_abnormal_lysosome_physiology | 1.94003665 |
| 16 | MP0001873_stomach_inflammation | 1.90832645 |
| 17 | MP0001666_abnormal_nutrient_absorption | 1.87594760 |
| 18 | MP0001800_abnormal_humoral_immune | 1.86940907 |
| 19 | MP0008260_abnormal_autophagy | 1.83446013 |
| 20 | MP0003436_decreased_susceptibility_to | 1.83037224 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.77099543 |
| 22 | MP0005671_abnormal_response_to | 1.72484456 |
| 23 | MP0009785_altered_susceptibility_to | 1.72221116 |
| 24 | MP0001790_abnormal_immune_system | 1.69088016 |
| 25 | MP0005387_immune_system_phenotype | 1.69088016 |
| 26 | MP0005083_abnormal_biliary_tract | 1.68647936 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.67566095 |
| 28 | * MP0005025_abnormal_response_to | 1.64436067 |
| 29 | MP0000609_abnormal_liver_physiology | 1.60043548 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.56901156 |
| 31 | MP0004381_abnormal_hair_follicle | 1.55992949 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.54749843 |
| 33 | MP0003724_increased_susceptibility_to | 1.53732478 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.52513987 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.47649937 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.47413992 |
| 37 | * MP0002723_abnormal_immune_serum | 1.47118273 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.42998092 |
| 39 | MP0001819_abnormal_immune_cell | 1.40770501 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.39845057 |
| 41 | MP0004947_skin_inflammation | 1.39782644 |
| 42 | MP0002398_abnormal_bone_marrow | 1.39708147 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.39408732 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.39028975 |
| 45 | MP0005332_abnormal_amino_acid | 1.38109795 |
| 46 | MP0002006_tumorigenesis | 1.37849961 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.36418190 |
| 48 | MP0001853_heart_inflammation | 1.36258053 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.35102111 |
| 50 | * MP0008469_abnormal_protein_level | 1.34444604 |
| 51 | MP0001764_abnormal_homeostasis | 1.31722465 |
| 52 | MP0000716_abnormal_immune_system | 1.29619901 |
| 53 | MP0002419_abnormal_innate_immunity | 1.29209627 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.28461954 |
| 55 | MP0004264_abnormal_extraembryonic_tissu | 1.27188439 |
| 56 | MP0002722_abnormal_immune_system | 1.26242673 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.25583896 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.25335380 |
| 59 | MP0003186_abnormal_redox_activity | 1.23788693 |
| 60 | MP0003866_abnormal_defecation | 1.21944368 |
| 61 | MP0001849_ear_inflammation | 1.20990973 |
| 62 | MP0002405_respiratory_system_inflammati | 1.19668111 |
| 63 | MP0002429_abnormal_blood_cell | 1.19486214 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.18808470 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.18808470 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.18791564 |
| 67 | MP0005310_abnormal_salivary_gland | 1.16115985 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.15187664 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.13027633 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12043972 |
| 71 | MP0006054_spinal_hemorrhage | 1.11430467 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.10866317 |
| 73 | MP0000598_abnormal_liver_morphology | 1.07958756 |
| 74 | MP0000678_abnormal_parathyroid_gland | 1.07704172 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.05720090 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.03710260 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.03200003 |
| 78 | MP0000490_abnormal_crypts_of | 1.02854580 |
| 79 | MP0003315_abnormal_perineum_morphology | 1.02423429 |
| 80 | MP0002118_abnormal_lipid_homeostasis | 1.02003788 |
| 81 | MP0002132_abnormal_respiratory_system | 1.01089646 |
| 82 | MP0003693_abnormal_embryo_hatching | 1.00999174 |
| 83 | MP0005670_abnormal_white_adipose | 1.00430127 |
| 84 | MP0009764_decreased_sensitivity_to | 1.00268007 |
| 85 | MP0009763_increased_sensitivity_to | 0.99823100 |
| 86 | MP0001851_eye_inflammation | 0.98827566 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.96640303 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 0.96491692 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.96251294 |
| 90 | MP0009379_abnormal_foot_pigmentation | 0.94117138 |
| 91 | MP0003705_abnormal_hypodermis_morpholog | 0.93151281 |
| 92 | MP0000703_abnormal_thymus_morphology | 0.92309174 |
| 93 | MP0004510_myositis | 0.92094213 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.90899257 |
| 95 | MP0005451_abnormal_body_composition | 0.90242998 |
| 96 | MP0000858_altered_metastatic_potential | 0.89484051 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.89025653 |
| 98 | MP0002796_impaired_skin_barrier | 0.89017602 |
| 99 | MP0005390_skeleton_phenotype | 0.88299424 |
| 100 | MP0003303_peritoneal_inflammation | 0.88280073 |
| 101 | MP0006082_CNS_inflammation | 0.85464629 |
| 102 | MP0003195_calcinosis | 0.83120337 |
| 103 | MP0003868_abnormal_feces_composition | 0.80040923 |
| 104 | MP0009931_abnormal_skin_appearance | 0.80038279 |
| 105 | MP0002254_reproductive_system_inflammat | 0.78400827 |
| 106 | MP0003011_delayed_dark_adaptation | 0.78063733 |
| 107 | MP0002933_joint_inflammation | 0.78057970 |
| 108 | MP0005023_abnormal_wound_healing | 0.77467163 |
| 109 | MP0001663_abnormal_digestive_system | 0.77148876 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.76660183 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.76185029 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.75900247 |
| 113 | MP0005501_abnormal_skin_physiology | 0.75774721 |
| 114 | MP0003279_aneurysm | 0.74838708 |
| 115 | MP0000477_abnormal_intestine_morphology | 0.74295928 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.74230790 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.73379473 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.72489550 |
| 119 | MP0002928_abnormal_bile_duct | 0.71724543 |
| 120 | MP0005166_decreased_susceptibility_to | 0.71692880 |
| 121 | MP0004147_increased_porphyrin_level | 0.71274199 |
| 122 | MP0009278_abnormal_bone_marrow | 0.70721251 |
| 123 | * MP0009642_abnormal_blood_homeostasis | 0.70225646 |
| 124 | MP0004858_abnormal_nervous_system | 0.69166344 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.68778450 |
| 126 | MP0000249_abnormal_blood_vessel | 0.68121874 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.67045794 |
| 128 | MP0003795_abnormal_bone_structure | 0.64045629 |
| 129 | MP0001216_abnormal_epidermal_layer | 0.61167358 |
| 130 | MP0003448_altered_tumor_morphology | 0.60148489 |
| 131 | MP0005375_adipose_tissue_phenotype | 0.59455069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.39048682 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.09214991 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.09105969 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.79422077 |
| 5 | Increased IgE level (HP:0003212) | 3.72705242 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.64227355 |
| 7 | Deep venous thrombosis (HP:0002625) | 3.59374683 |
| 8 | Meningitis (HP:0001287) | 3.48298187 |
| 9 | Myositis (HP:0100614) | 3.45853795 |
| 10 | Obstructive lung disease (HP:0006536) | 3.37895155 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.37895155 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.31658382 |
| 13 | Xanthomatosis (HP:0000991) | 3.30981109 |
| 14 | Cellulitis (HP:0100658) | 3.26644442 |
| 15 | Thrombocytosis (HP:0001894) | 3.25739815 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 3.20329712 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.15880666 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.15880666 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.14615411 |
| 20 | Polycythemia (HP:0001901) | 3.11108378 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.09388950 |
| 22 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.00057209 |
| 23 | Hyperammonemia (HP:0001987) | 2.90661505 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.88622184 |
| 25 | Chronic otitis media (HP:0000389) | 2.87151044 |
| 26 | Vasculitis (HP:0002633) | 2.85568797 |
| 27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.84597446 |
| 28 | IgM deficiency (HP:0002850) | 2.82365612 |
| 29 | Abnormal number of erythroid precursors (HP:0012131) | 2.80356460 |
| 30 | Complement deficiency (HP:0004431) | 2.74854297 |
| 31 | Joint hemorrhage (HP:0005261) | 2.74568350 |
| 32 | Pustule (HP:0200039) | 2.70482046 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 2.68403731 |
| 34 | Hemorrhage of the eye (HP:0011885) | 2.67638172 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 2.66526132 |
| 36 | Emphysema (HP:0002097) | 2.65383459 |
| 37 | Recurrent bronchitis (HP:0002837) | 2.65350449 |
| 38 | Encephalitis (HP:0002383) | 2.64969842 |
| 39 | Orchitis (HP:0100796) | 2.63621545 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.62345812 |
| 41 | Hyperglycinuria (HP:0003108) | 2.60227576 |
| 42 | Reticulocytopenia (HP:0001896) | 2.55720999 |
| 43 | Hypertensive crisis (HP:0100735) | 2.55393162 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55115843 |
| 45 | Ketosis (HP:0001946) | 2.52207812 |
| 46 | Nasal polyposis (HP:0100582) | 2.52192350 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.51239620 |
| 48 | Hypochromic anemia (HP:0001931) | 2.49766141 |
| 49 | Hyperbilirubinemia (HP:0002904) | 2.49359273 |
| 50 | Recurrent viral infections (HP:0004429) | 2.49248572 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.45922517 |
| 52 | Fat malabsorption (HP:0002630) | 2.45640028 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.44428749 |
| 54 | Broad face (HP:0000283) | 2.44028645 |
| 55 | Epistaxis (HP:0000421) | 2.43664317 |
| 56 | Gingivitis (HP:0000230) | 2.43631339 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.43485830 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43485830 |
| 59 | Gingival bleeding (HP:0000225) | 2.42674203 |
| 60 | Malnutrition (HP:0004395) | 2.42617800 |
| 61 | Seborrheic dermatitis (HP:0001051) | 2.40429715 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.40312720 |
| 63 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.39942512 |
| 64 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.39527696 |
| 65 | Urticaria (HP:0001025) | 2.38556462 |
| 66 | J-shaped sella turcica (HP:0002680) | 2.37745231 |
| 67 | Stomatitis (HP:0010280) | 2.34857101 |
| 68 | Abnormality of glycine metabolism (HP:0010895) | 2.34577066 |
| 69 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.34577066 |
| 70 | Polygenic inheritance (HP:0010982) | 2.34222340 |
| 71 | Hyperglycinemia (HP:0002154) | 2.34005707 |
| 72 | Granulocytopenia (HP:0001913) | 2.33371792 |
| 73 | Abnormality of T cells (HP:0002843) | 2.32977089 |
| 74 | Recurrent fungal infections (HP:0002841) | 2.31625011 |
| 75 | Abnormality of T cell physiology (HP:0011840) | 2.31567156 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31530683 |
| 77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.31113621 |
| 78 | Colitis (HP:0002583) | 2.30802949 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.30615516 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.30178712 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.30107709 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.29965365 |
| 83 | Increased IgM level (HP:0003496) | 2.29366751 |
| 84 | Petechiae (HP:0000967) | 2.28901263 |
| 85 | Acanthocytosis (HP:0001927) | 2.27598819 |
| 86 | Chest pain (HP:0100749) | 2.27042094 |
| 87 | Hypoplasia of the thymus (HP:0000778) | 2.26603374 |
| 88 | Hypoglycemic coma (HP:0001325) | 2.25966952 |
| 89 | Abnormality of the fingertips (HP:0001211) | 2.24395906 |
| 90 | Prolonged bleeding time (HP:0003010) | 2.23831301 |
| 91 | Increased serum ferritin (HP:0003281) | 2.20515170 |
| 92 | Macrocytic anemia (HP:0001972) | 2.20492596 |
| 93 | Abnormal platelet function (HP:0011869) | 2.19360250 |
| 94 | Impaired platelet aggregation (HP:0003540) | 2.19360250 |
| 95 | Vacuolated lymphocytes (HP:0001922) | 2.18882197 |
| 96 | Aplastic anemia (HP:0001915) | 2.16958058 |
| 97 | Abnormality of complement system (HP:0005339) | 2.16927690 |
| 98 | Abnormality of the intrinsic pathway (HP:0010989) | 2.15683406 |
| 99 | T lymphocytopenia (HP:0005403) | 2.14922587 |
| 100 | Agammaglobulinemia (HP:0004432) | 2.14909204 |
| 101 | Optic neuritis (HP:0100653) | 2.14792933 |
| 102 | Retrobulbar optic neuritis (HP:0100654) | 2.14792933 |
| 103 | Hypolipoproteinemia (HP:0010981) | 2.13239952 |
| 104 | Recurrent bacterial skin infections (HP:0005406) | 2.13018208 |
| 105 | Pulmonary infiltrates (HP:0002113) | 2.12300833 |
| 106 | Restrictive lung disease (HP:0002091) | 2.11568067 |
| 107 | Osteomyelitis (HP:0002754) | 2.10645841 |
| 108 | Myocardial infarction (HP:0001658) | 2.10451812 |
| 109 | Purpura (HP:0000979) | 2.09651325 |
| 110 | Hypergammaglobulinemia (HP:0010702) | 2.09631007 |
| 111 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.08659053 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.08410092 |
| 113 | Viral hepatitis (HP:0006562) | 2.07792066 |
| 114 | Microcytic anemia (HP:0001935) | 2.07598069 |
| 115 | Steatorrhea (HP:0002570) | 2.07022937 |
| 116 | Thin bony cortex (HP:0002753) | 2.06745653 |
| 117 | Hypercholesterolemia (HP:0003124) | 2.05726449 |
| 118 | Abnormality of T cell number (HP:0011839) | 2.05677290 |
| 119 | Gastrointestinal dysmotility (HP:0002579) | 2.05223894 |
| 120 | Eczematoid dermatitis (HP:0000976) | 2.04602665 |
| 121 | Hypertriglyceridemia (HP:0002155) | 2.03849705 |
| 122 | Premature loss of primary teeth (HP:0006323) | 2.03452246 |
| 123 | Panhypogammaglobulinemia (HP:0003139) | 2.02634091 |
| 124 | Skin ulcer (HP:0200042) | 2.01864060 |
| 125 | Generalized aminoaciduria (HP:0002909) | 2.01736329 |
| 126 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00925526 |
| 127 | Autoimmune thrombocytopenia (HP:0001973) | 2.00354688 |
| 128 | Recurrent skin infections (HP:0001581) | 1.99824314 |
| 129 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.98882500 |
| 130 | Late onset (HP:0003584) | 1.98623907 |
| 131 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96780495 |
| 132 | Gastrointestinal stroma tumor (HP:0100723) | 1.95806382 |
| 133 | Pallor (HP:0000980) | 1.95402645 |
| 134 | Periodontitis (HP:0000704) | 1.95183886 |
| 135 | Lymphopenia (HP:0001888) | 1.95132817 |
| 136 | Skin rash (HP:0000988) | 1.93506274 |
| 137 | Easy fatigability (HP:0003388) | 1.93048189 |
| 138 | Basal cell carcinoma (HP:0002671) | 1.92245495 |
| 139 | Hepatosplenomegaly (HP:0001433) | 1.91722340 |
| 140 | Recurrent abscess formation (HP:0002722) | 1.91703045 |
| 141 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.91559626 |
| 142 | Villous atrophy (HP:0011473) | 1.91559626 |
| 143 | Menorrhagia (HP:0000132) | 1.90995896 |
| 144 | Recurrent lower respiratory tract infections (HP:0002783) | 1.90805379 |
| 145 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90463264 |
| 146 | Ureteral stenosis (HP:0000071) | 1.90333756 |
| 147 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90174098 |
| 148 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89517946 |
| 149 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89517946 |
| 150 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89517946 |
| 151 | Reduced antithrombin III activity (HP:0001976) | 1.88517613 |
| 152 | Elevated hepatic transaminases (HP:0002910) | 1.87381230 |
| 153 | Recurrent sinusitis (HP:0011108) | 1.86696074 |
| 154 | Papilloma (HP:0012740) | 1.86330863 |
| 155 | Verrucae (HP:0200043) | 1.86330863 |
| 156 | Joint stiffness (HP:0001387) | 1.86209951 |
| 157 | Autoimmune hemolytic anemia (HP:0001890) | 1.85479166 |
| 158 | Esophageal varix (HP:0002040) | 1.84913196 |
| 159 | Systemic lupus erythematosus (HP:0002725) | 1.84364705 |
| 160 | Septate vagina (HP:0001153) | 1.83995410 |
| 161 | Sepsis (HP:0100806) | 1.83777693 |
| 162 | Hemoptysis (HP:0002105) | 1.83622800 |
| 163 | Interstitial pulmonary disease (HP:0006530) | 1.82877341 |
| 164 | Obstructive sleep apnea (HP:0002870) | 1.81025547 |
| 165 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81019770 |
| 166 | Mucopolysacchariduria (HP:0008155) | 1.81019770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.12800362 |
| 2 | ERN1 | 3.08977165 |
| 3 | SMG1 | 2.98267501 |
| 4 | BCKDK | 2.82411672 |
| 5 | PRPF4B | 2.80156889 |
| 6 | * TBK1 | 2.60087312 |
| 7 | RIPK4 | 2.50274912 |
| 8 | TYK2 | 2.32277847 |
| 9 | NME2 | 2.22748805 |
| 10 | FGFR4 | 2.21877137 |
| 11 | GRK6 | 2.18111074 |
| 12 | KIT | 2.06616480 |
| 13 | MAP3K10 | 2.04281629 |
| 14 | KDR | 2.04023673 |
| 15 | FLT3 | 2.00074419 |
| 16 | EEF2K | 1.95006657 |
| 17 | TRIB3 | 1.90626939 |
| 18 | ZAP70 | 1.90165382 |
| 19 | PKN2 | 1.87704891 |
| 20 | SIK1 | 1.80512785 |
| 21 | MAP2K3 | 1.80259081 |
| 22 | BTK | 1.76130367 |
| 23 | TGFBR2 | 1.69849402 |
| 24 | JAK3 | 1.68352617 |
| 25 | MAP3K13 | 1.67945694 |
| 26 | LRRK2 | 1.67755323 |
| 27 | TGFBR1 | 1.66906451 |
| 28 | TEC | 1.61933508 |
| 29 | TXK | 1.54749144 |
| 30 | STK10 | 1.49524350 |
| 31 | BLK | 1.48971902 |
| 32 | FES | 1.40838621 |
| 33 | STK16 | 1.39751483 |
| 34 | PIM2 | 1.38674759 |
| 35 | CSF1R | 1.38477734 |
| 36 | SIK2 | 1.35409622 |
| 37 | * IKBKE | 1.33590024 |
| 38 | SIK3 | 1.30422146 |
| 39 | TAOK3 | 1.29880538 |
| 40 | IRAK3 | 1.29349966 |
| 41 | MAPK11 | 1.27885727 |
| 42 | TLK1 | 1.27092498 |
| 43 | RPS6KA4 | 1.25656698 |
| 44 | MAP3K11 | 1.17973754 |
| 45 | CDC42BPA | 1.15670923 |
| 46 | EPHA2 | 1.13803033 |
| 47 | ITK | 1.13639899 |
| 48 | MST4 | 1.10238903 |
| 49 | TIE1 | 1.10003309 |
| 50 | MAP3K14 | 1.09867874 |
| 51 | MAP3K3 | 1.08322373 |
| 52 | SYK | 1.04784230 |
| 53 | IRAK4 | 1.03350249 |
| 54 | ICK | 1.03303376 |
| 55 | NLK | 1.01927155 |
| 56 | CSK | 0.99364691 |
| 57 | TESK2 | 0.98581984 |
| 58 | JAK1 | 0.97234912 |
| 59 | PIM1 | 0.96573684 |
| 60 | CDK12 | 0.95469298 |
| 61 | HIPK2 | 0.95270694 |
| 62 | RPS6KB2 | 0.93697378 |
| 63 | CDK4 | 0.89906326 |
| 64 | LCK | 0.85812850 |
| 65 | TAOK1 | 0.84649904 |
| 66 | MARK2 | 0.83747048 |
| 67 | MAPKAPK3 | 0.83153398 |
| 68 | TAOK2 | 0.82426126 |
| 69 | VRK2 | 0.81956938 |
| 70 | LYN | 0.80658397 |
| 71 | * IKBKB | 0.80363548 |
| 72 | MAP3K1 | 0.79988693 |
| 73 | BMX | 0.78936258 |
| 74 | PTK6 | 0.77293796 |
| 75 | NEK9 | 0.75492493 |
| 76 | EIF2AK1 | 0.73434757 |
| 77 | MAP2K2 | 0.71878576 |
| 78 | MAP3K7 | 0.70522936 |
| 79 | JAK2 | 0.69135831 |
| 80 | HCK | 0.66340443 |
| 81 | RPS6KA2 | 0.65889230 |
| 82 | MAP3K8 | 0.65525897 |
| 83 | TESK1 | 0.65022417 |
| 84 | PIK3CG | 0.63349540 |
| 85 | MAPK7 | 0.61973796 |
| 86 | TTN | 0.61522906 |
| 87 | MYLK | 0.60684777 |
| 88 | CDK7 | 0.59962597 |
| 89 | FGFR3 | 0.59037482 |
| 90 | PDPK1 | 0.58184220 |
| 91 | MARK3 | 0.57365366 |
| 92 | PDK1 | 0.56642355 |
| 93 | PAK4 | 0.54995186 |
| 94 | NEK2 | 0.54741743 |
| 95 | CAMKK1 | 0.54496972 |
| 96 | MAPKAPK2 | 0.53147644 |
| 97 | STK4 | 0.52616359 |
| 98 | CHUK | 0.52345087 |
| 99 | MST1R | 0.52168903 |
| 100 | WEE1 | 0.51943966 |
| 101 | MAPK4 | 0.51751706 |
| 102 | RIPK1 | 0.51689870 |
| 103 | IRAK2 | 0.51433229 |
| 104 | FGR | 0.51372343 |
| 105 | MAP3K6 | 0.49217349 |
| 106 | TNK2 | 0.49082344 |
| 107 | ARAF | 0.48864660 |
| 108 | PRKG2 | 0.48726568 |
| 109 | ACVR1B | 0.48003251 |
| 110 | MAPK12 | 0.46854209 |
| 111 | CDK6 | 0.46202666 |
| 112 | RPS6KA5 | 0.45514713 |
| 113 | RPS6KA6 | 0.44292033 |
| 114 | PRKAA2 | 0.43150005 |
| 115 | SCYL2 | 0.40880004 |
| 116 | MELK | 0.40768509 |
| 117 | ILK | 0.40308213 |
| 118 | MATK | 0.40176674 |
| 119 | MAPK15 | 0.39141782 |
| 120 | AURKB | 0.38612774 |
| 121 | PRKD2 | 0.37826709 |
| 122 | CLK1 | 0.37552096 |
| 123 | PASK | 0.37045131 |
| 124 | RPS6KC1 | 0.35409268 |
| 125 | RPS6KL1 | 0.35409268 |
| 126 | EIF2AK3 | 0.35274939 |
| 127 | DYRK1B | 0.34776550 |
| 128 | MAP2K6 | 0.32816896 |
| 129 | EPHB1 | 0.32315485 |
| 130 | PRKCQ | 0.32281565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.01320968 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71114802 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.64462234 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.55443981 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.52654434 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.50370659 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16724964 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.05273332 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.01358464 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98825009 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98521816 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.98482173 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98399036 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96052910 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87949756 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82865768 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.76087382 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75990760 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73368883 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72675398 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.72376972 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.71827110 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71797389 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.70424716 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69267188 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64229670 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.62212206 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60559628 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58724464 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56232592 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.54907889 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.47634495 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.44708543 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42783420 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42164118 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41781108 |
| 37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.40286035 |
| 38 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37696634 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.37322878 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34430803 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33177362 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.32321764 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.31973495 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30843125 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.30196030 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28790355 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28564414 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27621513 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.26853020 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26745831 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26367067 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.24931622 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20031242 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18159426 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17298962 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16887805 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 1.15995227 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15159777 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14822674 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10086231 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 1.09091696 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06344729 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05636251 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05488188 |
| 65 | * Hepatitis B_Homo sapiens_hsa05161 | 1.04877092 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04700888 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04007276 |
| 68 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03015863 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02650300 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02598950 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01548304 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.01468438 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00562697 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99742050 |
| 75 | Mismatch repair_Homo sapiens_hsa03430 | 0.99707372 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97350792 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.92988124 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92468212 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92276603 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.89829626 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88190928 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87232125 |
| 83 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86530856 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86114487 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84374185 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.84068674 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.83987996 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83216037 |
| 89 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81822532 |
| 90 | * Measles_Homo sapiens_hsa05162 | 0.80995667 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80948663 |
| 92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79329081 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.79324541 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78641697 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77964866 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76495030 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75949006 |
| 98 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75147389 |
| 99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.75127370 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.74649580 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.74325808 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73406658 |
| 103 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.72488531 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72072128 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71914439 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71912783 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71574012 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70727127 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.69951384 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68732213 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.67950500 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67053803 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65808457 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64594281 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64038023 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59957623 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59566816 |
| 118 | Homologous recombination_Homo sapiens_hsa03440 | 0.59088066 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56276372 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55513109 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55299188 |
| 122 | Legionellosis_Homo sapiens_hsa05134 | 0.55281338 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54692403 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54339646 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54042669 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53727456 |
| 127 | * Pertussis_Homo sapiens_hsa05133 | 0.52910176 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51465198 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51441419 |
| 130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50484652 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50251859 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49885009 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49831286 |
| 134 | Spliceosome_Homo sapiens_hsa03040 | 0.49576475 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.49221302 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48896345 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48224671 |
| 138 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47994067 |
| 139 | Salmonella infection_Homo sapiens_hsa05132 | 0.47947054 |
| 140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46799574 |
| 141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46238926 |
| 142 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45669348 |
| 143 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44765902 |
| 144 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44582730 |
| 145 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43799034 |
| 146 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42731508 |
| 147 | Proteasome_Homo sapiens_hsa03050 | 0.42140216 |
| 148 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41992020 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41642719 |
| 150 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41412029 |
| 151 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41132130 |
| 152 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40760257 |
| 153 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40289362 |
| 154 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40232768 |
| 155 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38898769 |
| 156 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38578901 |
| 157 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37764982 |
| 158 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34397532 |
| 159 | * Influenza A_Homo sapiens_hsa05164 | 0.34092516 |
| 160 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33461317 |
| 161 | * Hepatitis C_Homo sapiens_hsa05160 | 0.33334065 |
| 162 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33143651 |
| 163 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33114899 |
| 164 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.32696107 |
| 165 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32417319 |

